As of 2025-07-07, the Relative Valuation of PharmaCyte Biotech Inc (PMCB) is 0.60 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.11 USD, the upside of PharmaCyte Biotech Inc based on Relative Valuation is -45.9%.
The range of the Relative Valuation is 0.02 - 1.18 USD.
| Range | Selected | |
| Trailing P/E multiples | 0.4x - 0.4x | 0.4x |
| Forward P/E multiples | 0.4x - 0.4x | 0.4x |
| Fair Price | 0.02 - 1.18 | 0.60 |
| Upside | -98.2% - 6.4% | -45.9% |
| Date | P/E |
| 2025-05-07 | 0.37 |
| 2025-05-06 | 0.38 |
| 2025-05-05 | 0.41 |
| 2025-05-02 | 0.41 |
| 2025-05-01 | 0.40 |
| 2025-04-30 | 0.42 |
| 2025-04-29 | 0.42 |
| 2025-04-28 | 0.41 |
| 2025-04-25 | 0.41 |
| 2025-04-24 | 0.41 |
| 2025-04-23 | 0.40 |
| 2025-04-22 | 0.39 |
| 2025-04-21 | 0.38 |
| 2025-04-17 | 0.40 |
| 2025-04-16 | 0.39 |
| 2025-04-15 | 0.43 |
| 2025-04-14 | 0.41 |
| 2025-04-11 | 0.42 |
| 2025-04-10 | 0.39 |
| 2025-04-09 | 0.41 |
| 2025-04-08 | 0.41 |
| 2025-04-07 | 0.39 |
| 2025-04-04 | 0.42 |
| 2025-04-03 | 0.42 |
| 2025-04-02 | 0.44 |
| 2025-04-01 | 0.44 |
| 2025-03-31 | 0.42 |
| 2025-03-28 | 0.45 |
| 2025-03-27 | 0.47 |
| 2025-03-26 | 0.50 |
| 2025-03-25 | 0.53 |
| 2025-03-24 | 0.53 |
| 2025-03-21 | 0.54 |
| 2025-03-20 | 0.57 |
| 2025-03-19 | 0.57 |
| 2025-03-18 | 0.51 |
| 2025-03-17 | 0.54 |
| 2025-03-14 | 0.54 |
| 2025-03-13 | 0.57 |
| 2025-03-12 | 0.56 |
| 2025-03-11 | 0.60 |
| 2025-03-10 | 0.60 |
| 2025-03-07 | 0.60 |
| 2025-03-06 | 0.60 |
| 2025-03-05 | 0.61 |
| 2025-03-04 | 0.58 |
| 2025-03-03 | 0.58 |
| 2025-02-28 | 0.60 |
| 2025-02-27 | 0.59 |
| 2025-02-26 | 0.58 |